Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)

American Journal of Cardiology

Volumn 94, Issue 5, 2004, Pages 637-640

  Sadeghi, H Mehrdad ^a   Grines, Cindy L ^b   Chandra, Harish R ^b   Mehran, Roxana ^c   Fahy, Martin ^c   Cox, David A ^d   Garcia, Eulogio ^e   Tcheng, James E ^f   Griffin, John J ^g   Stuckey, Thomas D ^h   Lansky, Alexandra J ^c   O'Neill, William W ^b   Stone, Gregg W ^c  

^a SHARP HEALTHCARE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d Mid Carolina Cardiology   (United States)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g Sentara Virginia Beach General Hospital   (United States)

^h MOSES H CONE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART MOVEMENT; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; APPOINTMENTS AND SCHEDULES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERSONNEL STAFFING AND SCHEDULING; TIME FACTORS; TREATMENT OUTCOME;

EID: 4444235365     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.05.030     Document Type: Article

References (20)

1. G.W. Stone, C.L. Grines, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, and J.D. Carroll Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
2. C.M. Bell, and D.A. Redelmeier Mortality among patients admitted to hospitals on weekends as compared with weekdays N Engl J Med 345 2001 663 668
3. T.J. Ryan, E.M. Antman, N.H. Brooks, R.M. Califf, L.D. Hillis, L.F. Hiratzka, E. Rapaport, B. Riegel, R.O. Russell, and E.E. Smith III 1999 update ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
4. D.J. Magid, B.N. Calonge, J.S. Rumsfeld, J.G. Canto, P.D. Frederick, N.R. Every, and H.V. Barron Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy JAMA 284 2000 3131 3138
5. R.H. Mehta, C.K. Montoye, M. Gallogly, P. Baker, A. Blount, J. Faul, C. Roychoudhury, S. Borzak, S. Fox, and M. Franklin Improving quality of care for acute myocardial infarction the Guidelines Applied in Practice (GAP) Initiative JAMA 287 2002 1269 1276
6. A. Doorey, S. Patel, C. Reese, R. O'Connor, N. Geloo, S. Sutherland, N. Price, E. Gleasner, and R. Rodrigue Dangers of delay of initiation of either thrombolysis or primary angioplasty in acute myocardial infarction with increasing use of primary angioplasty Am J Cardiol 81 1998 1173 1177
7. B.G. Angeja, C.M. Gibson, R. Chin, P.D. Frederick, N.R. Every, A.M. Ross, G.W. Stone, and H.V. Barron Predictors of door-to-balloon delay in primary angioplasty Am J Cardiol 89 2002 1156 1161
8. The GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
9. The LATE Investigators Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction Lancet 342 1993 759 766
10. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction Lancet 342 1993 767 772
11. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
12. L.K. Newby, W.R. Rutsch, R.M. Califf, M.L. Simoons, P.E. Aylward, P.W. Armstrong, L.H. Woodlief, K.L. Lee, E.J. Topol, and F. van de Werf Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators J Am Coll Cardiol 27 1996 1646 1655
13. B.R. Brodie, T.D. Stuckey, T.C. Wall, G. Kissling, C.J. Hansen, D.B. Muncy, R.A. Weintraub, and T.A. Kelly Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 1998 1312 1319
14. C.P. Cannon, C.M. Gibson, C.T. Lambrew, D.A. Shoultz, D. Levy, W.J. French, J.M. Gore, W.D. Weaver, W.J. Rogers, and A.J. Tiefenbrunn Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
15. P.B. Berger, S.G. Ellis, D.R. Holmes Jr, C.B. Granger, D.A. Criger, A. Betriu, E.J. Topol, and R.M. Califf Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial Circulation 100 1999 14 20
16. D. Antoniucci, R. Valenti, A. Migliorini, G. Moschi, M. Trapani, P. Buonamici, G. Cerisano, L. Bolognese, and G.M. Santoro Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty Am J Cardiol 89 2002 1248 1252
17. B.R. Brodie, G.W. Stone, M.C. Morice, D.A. Cox, E. Garcia, L.A. Mattos, J. Boura, W.W. O'Neill, T.D. Stuckey, and S. Milks Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial) Am J Cardiol 88 2001 1085 1090
18. A.L. Liem, A.W.J. Van't Hof, J.C.A. Hoorntje, M.J. De Boer, H. Suryapranata, and F. Zijlstra Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty J Am Coll Cardiol 32 1998 629 633
19. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 randomised trials Lancet 361 2003 13 20
20. H.R. Andersen, T.T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, P. Thayssen, U. Abildgaard, F. Pedersen, J.K. Madsen, and P. Grande Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction N Engl J Med 349 2003 733 742